drugset / Trial / NCT02979912

Autologous Platelet Lysate in Corneal Epithelial Defects

NCT02979912

Phase 1/2 Completed 10 enrolled Hanan Jafar
NaSingle-groupOpen-labelTreatment

Summary

Patients diagnosed with persistent corneal epithelial ulcers will be treated with autologous platelet lysate.

Timeline

Start
2017-02-16
Primary completion
2019-01-15
Completion
2019-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Lysate Unknown Topical

Indications